
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Kappa free light chain concentration in serum is reduced after CD20-depletion with ocrelizumab - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E49F7A8AF1AC03059F7A00491563F2.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="neurrp">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372195/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Neurological Research and Practice">
<meta name="citation_title" content="Kappa free light chain concentration in serum is reduced after CD20-depletion with ocrelizumab">
<meta name="citation_author" content="Franz Felix Konen">
<meta name="citation_author_institution" content="Department of Neurology, Hannover Medical School, Hannover, Germany">
<meta name="citation_author" content="Gudrun Mechthild Körner">
<meta name="citation_author_institution" content="Department of Neurology, Universitätsspital Zürich, Zurich, Switzerland">
<meta name="citation_author" content="Martin W Hümmert">
<meta name="citation_author_institution" content="Department of Neurology, Hannover Medical School, Hannover, Germany">
<meta name="citation_author" content="Philipp Sebastian Gehring">
<meta name="citation_author_institution" content="Department of Neurology, Hannover Medical School, Hannover, Germany">
<meta name="citation_author" content="Philipp Schwenkenbecher">
<meta name="citation_author_institution" content="Department of Neurology, Hannover Medical School, Hannover, Germany">
<meta name="citation_author" content="Konstantin Fritz Jendretzky">
<meta name="citation_author_institution" content="Department of Neurology, Hannover Medical School, Hannover, Germany">
<meta name="citation_author" content="Sandra Nay">
<meta name="citation_author_institution" content="Department of Neurology, Hannover Medical School, Hannover, Germany">
<meta name="citation_author" content="Nora Möhn">
<meta name="citation_author_institution" content="Department of Neurology, Hannover Medical School, Hannover, Germany">
<meta name="citation_author" content="Lea Grote-Levi">
<meta name="citation_author_institution" content="Department of Neurology, Hannover Medical School, Hannover, Germany">
<meta name="citation_author" content="Kurt-Wolfram Sühs">
<meta name="citation_author_institution" content="Department of Neurology, Hannover Medical School, Hannover, Germany">
<meta name="citation_author" content="Elke Voß">
<meta name="citation_author_institution" content="Neurocenter Barsinghausen, Barsinghausen, Germany">
<meta name="citation_author" content="Refik Pul">
<meta name="citation_author_institution" content="Department of Neurology, University Medicine Essen, Essen, Germany">
<meta name="citation_author_institution" content="Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, Essen, Germany">
<meta name="citation_author" content="Torsten Witte">
<meta name="citation_author_institution" content="Department of Rheumatology &amp; Clinical Immunology, Hannover Medical School, Hannover, Germany">
<meta name="citation_author" content="Thomas Skripuletz">
<meta name="citation_author_institution" content="Department of Neurology, Hannover Medical School, Hannover, Germany">
<meta name="citation_author" content="Stefan Gingele">
<meta name="citation_author_institution" content="Department of Neurology, Hannover Medical School, Hannover, Germany">
<meta name="citation_publication_date" content="2025 Aug 22">
<meta name="citation_volume" content="7">
<meta name="citation_issue" content="1">
<meta name="citation_firstpage" content="58">
<meta name="citation_doi" content="10.1186/s42466-025-00419-7">
<meta name="citation_pmid" content="40847377">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372195/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372195/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372195/pdf/42466_2025_Article_419.pdf">
<meta name="description" content="Kappa free light chains (KFLC), a byproduct of immunoglobulin (Ig) synthesis by B-lineage cells, can serve as an indicator for inflammatory activity. In multiple sclerosis (MS), especially the intrathecal KFLC production has gained increasing ...">
<meta name="og:title" content="Kappa free light chain concentration in serum is reduced after CD20-depletion with ocrelizumab">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Kappa free light chains (KFLC), a byproduct of immunoglobulin (Ig) synthesis by B-lineage cells, can serve as an indicator for inflammatory activity. In multiple sclerosis (MS), especially the intrathecal KFLC production has gained increasing ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372195/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12372195">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s42466-025-00419-7"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/42466_2025_Article_419.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372195%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12372195/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12372195/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372195/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-neurrp.png" alt="Neurological Research and Practice logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Neurological Research and Practice" title="Link to Neurological Research and Practice" shape="default" href="https://neurolrespract.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Neurol Res Pract</button></div>. 2025 Aug 22;7(1):58. doi: <a href="https://doi.org/10.1186/s42466-025-00419-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s42466-025-00419-7</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Neurol%20Res%20Pract%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Neurol%20Res%20Pract%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Neurol%20Res%20Pract%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Neurol%20Res%20Pract%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Kappa free light chain concentration in serum is reduced after CD20-depletion with ocrelizumab</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Konen%20FF%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Franz Felix Konen</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Franz Felix Konen</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Hannover Medical School, Hannover, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Konen%20FF%22%5BAuthor%5D" class="usa-link"><span class="name western">Franz Felix Konen</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22K%C3%B6rner%20GM%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Gudrun Mechthild Körner</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Gudrun Mechthild Körner</span></h3>
<div class="p">
<sup>2</sup>Department of Neurology, Universitätsspital Zürich, Zurich, Switzerland </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22K%C3%B6rner%20GM%22%5BAuthor%5D" class="usa-link"><span class="name western">Gudrun Mechthild Körner</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22H%C3%BCmmert%20MW%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Martin W Hümmert</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Martin W Hümmert</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Hannover Medical School, Hannover, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22H%C3%BCmmert%20MW%22%5BAuthor%5D" class="usa-link"><span class="name western">Martin W Hümmert</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gehring%20PS%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Philipp Sebastian Gehring</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Philipp Sebastian Gehring</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Hannover Medical School, Hannover, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gehring%20PS%22%5BAuthor%5D" class="usa-link"><span class="name western">Philipp Sebastian Gehring</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schwenkenbecher%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Philipp Schwenkenbecher</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Philipp Schwenkenbecher</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Hannover Medical School, Hannover, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schwenkenbecher%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Philipp Schwenkenbecher</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jendretzky%20KF%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Konstantin Fritz Jendretzky</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Konstantin Fritz Jendretzky</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Hannover Medical School, Hannover, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jendretzky%20KF%22%5BAuthor%5D" class="usa-link"><span class="name western">Konstantin Fritz Jendretzky</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nay%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Sandra Nay</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Sandra Nay</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Hannover Medical School, Hannover, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nay%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sandra Nay</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22M%C3%B6hn%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Nora Möhn</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Nora Möhn</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Hannover Medical School, Hannover, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22M%C3%B6hn%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nora Möhn</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Grote-Levi%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Lea Grote-Levi</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Lea Grote-Levi</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Hannover Medical School, Hannover, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Grote-Levi%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lea Grote-Levi</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22S%C3%BChs%20KW%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Kurt-Wolfram Sühs</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Kurt-Wolfram Sühs</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Hannover Medical School, Hannover, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22S%C3%BChs%20KW%22%5BAuthor%5D" class="usa-link"><span class="name western">Kurt-Wolfram Sühs</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vo%C3%9F%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Elke Voß</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Elke Voß</span></h3>
<div class="p">
<sup>3</sup>Neurocenter Barsinghausen, Barsinghausen, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vo%C3%9F%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elke Voß</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pul%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Refik Pul</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Refik Pul</span></h3>
<div class="p">
<sup>4</sup>Department of Neurology, University Medicine Essen, Essen, Germany </div>
<div class="p">
<sup>5</sup>Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, Essen, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pul%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Refik Pul</span></a>
</div>
</div>
<sup>4,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Witte%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Torsten Witte</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Torsten Witte</span></h3>
<div class="p">
<sup>6</sup>Department of Rheumatology &amp; Clinical Immunology, Hannover Medical School, Hannover, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Witte%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Torsten Witte</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Skripuletz%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Thomas Skripuletz</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Thomas Skripuletz</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Hannover Medical School, Hannover, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Skripuletz%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Thomas Skripuletz</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gingele%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Stefan Gingele</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Stefan Gingele</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, Hannover Medical School, Hannover, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gingele%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Stefan Gingele</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Neurology, Hannover Medical School, Hannover, Germany </div>
<div id="Aff2">
<sup>2</sup>Department of Neurology, Universitätsspital Zürich, Zurich, Switzerland </div>
<div id="Aff3">
<sup>3</sup>Neurocenter Barsinghausen, Barsinghausen, Germany </div>
<div id="Aff4">
<sup>4</sup>Department of Neurology, University Medicine Essen, Essen, Germany </div>
<div id="Aff5">
<sup>5</sup>Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, Essen, Germany </div>
<div id="Aff6">
<sup>6</sup>Department of Rheumatology &amp; Clinical Immunology, Hannover Medical School, Hannover, Germany </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 May 20; Accepted 2025 Aug 6; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12372195  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40847377/" class="usa-link">40847377</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Kappa free light chains (KFLC), a byproduct of immunoglobulin (Ig) synthesis by B-lineage cells, can serve as an indicator for inflammatory activity. In multiple sclerosis (MS), especially the intrathecal KFLC production has gained increasing importance as a biomarker for central nervous system (CNS) inflammation and was included into the proposed 2024 revision of the McDonald criteria. In contrast, studies investigating the significance of KFLC in serum and the effects of disease-modifying therapies (DMT) on KFLC serum concentration in MS are rare. The aim of the present work was to investigate the impact of B cell depletion with ocrelizumab on KFLC concentrations in serum of MS patients and the ability of serum KFLC to monitor disease activity.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par2">50 MS patients were included in the present study– 38 with the diagnosis of relapsing MS (RMS) and 12 with diagnosis of primary-progressive MS (PPMS) -, who were treated with ocrelizumab for two years. Serum concentrations of albumin, immunoglobulins and KFLC as well as lymphocyte subsets were determined at baseline and after two years.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">Serum Ig and KFLC concentrations were found to be significantly lower after two years of ocrelizumab treatment (mean serum concentrations: KFLC: 9.5 mg/l vs. 7.8 mg/l, <em>p</em> = 0.0003; IgG: 9 g/l vs. 8 g/l, <em>p</em> = 0.0002; IgA: 2 g/l vs. 1.8 g/l, <em>p</em> = 0.0010; IgM: 1.8 g/l vs. 0.7 g/l, <em>p</em> &lt; 0.0001). Serum KFLC concentration did not correlate with clinical and paraclinical parameters of disease activity.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusions</h3>
<p id="Par4">Treatment with ocrelizumab reduces serum KFLC concentration in MS patients. However, serum KFLC concentration is not able to predict disease activity in these MS patients.</p></section><section id="sec5"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s42466-025-00419-7.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Multiple sclerosis, Ocrelizumab, Kappa free light chains, Serum, Biomarker</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par5">Kappa free light chains (KFLC) represent a surrogate marker for activity of B-cell lineage cells and especially plasma cells [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Therefore, the level of KFLC in serum are recognized as biomarker for inflammation in various autoimmune diseases, e.g. rheumatoid arthritis or Sjögren´s disease [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>–<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. Treatment with rituximab, a B-cell depleting monoclonal antibody against CD20, has been shown to result in a decrease of serum KFLC correlating with reduced disease activity in systemic rheumatoid diseases [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous systems (CNS) and therefore the focus has been on the intrathecal production of KFLC [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. The intrathecal fraction of KFLC has been increasingly recognized as biomarker of central nervous system (CNS) inflammation in MS and other neuro-inflammatory diseases and was therefore proposed for inclusion into the latest proposed revision of the McDonald criteria as additional diagnostic criterion [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Since intrathecal immunoglobulin (Ig) synthesis is an important pathophysiological component in the development of inflammatory activity associated with MS, the byproducts of Ig synthesis and secretion such as KFLC in cerebrospinal fluid (CSF) represent a promising biomarker for inflammatory activity [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>–<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. Therefore, the influence of the disease progression of MS as well as of disease-modifying therapies (DMT) on CSF concentrations of KFLC has been investigated to establish if intrathecal KFLC-production can serve as biomarker for therapy and disease monitoring. No influence of treatment with interferon-β-1a, fingolimod or alemtuzumab on KFLC concentration in CSF and serum was reported, whereas intrathecal application of rituximab led to a significant increase in KFLC concentration in CSF [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>–<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. In contrast, a cross-sectional study reported a decreased intrathecal KFLC fraction in MS patients receiving highly efficient DMT such as alemtuzumab, natalizumab, mitoxantrone and CD20-depleting therapies [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>].</p>
<p id="Par6">In contrast to the abundance of data regarding the intrathecal fraction of KFLC as a promising biomarker for disease activity in MS, data on serum KFLC in MS and the impact of immunomodulatory therapies are scarce. In a previous study, we investigated the influence of different acute treatments on the serum concentration of KFLC and found a rapid decrease in serum KFLC concentration by the intravenous administration of methylprednisolone [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>].</p>
<p id="Par7">Since KFLC in CSF and serum represent products of Ig synthesized by B cells, which are mainly characterized by expression of CD20, they might serve as a biomarker of CD20-depleting therapies such as ocrelizumab [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. Ocrelizumab is a humanized monoclonal anti-CD20 antibody, which has been approved for the treatment of MS patients with either a relapsing- (RMS) or primary-progressive (PPMS) disease course [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. Effective and profound depletion of CD20<sup>+</sup> B and T cells has been demonstrated already two weeks after a single application of 300 mg ocrelizumab [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. The number of CD20<sup>+</sup> lymphocytes in the peripheral blood is often analyzed to monitor the efficacy of treatment during therapy with a CD20 antibody. However, the degree of depletion of CD20<sup>+</sup> lymphocytes has been shown to not convincingly reflect disease activity in MS patients [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>, <a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. Therefore, new biomarkers for treatment decisions in patients with MS are needed [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>, <a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>].</p>
<p id="Par8">The aim of the present study was to assess the impact of treatment with the CD20 antibody ocrelizumab on serum KFLC levels and the ability of serum KFLC to monitor disease activity.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Patients</h3>
<p id="Par9">A total of 50 patients were prospectively included in this monocentric longitudinal study after giving written informed consent (8787_BO_K_2019). All patients presented to the Department of Neurology at Hannover Medical School (MHH) between 2018 and 2021. Patients were diagnosed with either RMS or PPMS and were treated with ocrelizumab. The therapeutic regimen of all patients consisted of an initial intravenous dose of 300 mg ocrelizumab, followed by a second dose of 300 mg after 14 days. Thereafter, a dose of 600 mg ocrelizumab was infused every 6 months. Serum samples of all included patients were collected immediately before the start of ocrelizumab treatment and after two years, when a total ocrelizumab dose of 2400 mg was infused. Previous DMT in the last 12 months prior to start of ocrelizumab was recorded. Patients were considered treatment-naïve if they had not received DMT ever before initiation of ocrelizumab therapy. DMT were discontinued and ocrelizumab was started after remission of therapeutic effects of the DMT. Clinical examinations including Expanded Disability Status Scale (EDSS) and the timed 25-foot walk test (T25FWT) were performed every 6 to 12 months [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>, <a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>].</p></section><section id="Sec4"><h3 class="pmc_sec_title">Disease activity</h3>
<p id="Par10">Clinical disease activity was defined as the occurrence of one or more relapses in RMS patients, which must have resulted in an increase of at least one point in any functional system score of the EDSS [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. Additionally, progression independent of relapse activity (PIRA) was also considered as clinical disease activity in RMS and PPMS patients and was evaluated according to previously established criteria [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. Confirmed disability worsening was determined based on a relapse-dependent or relapse-independent EDSS increase of + 1.5 points from a baseline of 0, + 1.0 point from a baseline between 1 and 5.5, or + 0.5 points from a baseline of ≥ 6.0; this change had to be confirmed after six months [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. MS disease activity in magnetic resonance imaging (MRI) was defined as onset of new T2 lesions in at least yearly performed 1.5 to 3T MRI in accordance with the MAGNIMS-CMSC-NAIMS guidelines, if they were typical of MS and appeared after treatment initiation [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>].</p></section><section id="Sec5"><h3 class="pmc_sec_title">Analytical procedures</h3>
<p id="Par11">All samples were analyzed according to routine diagnostic procedures in the Neurochemistry Laboratory of the Department of Neurology at MHH. The concentrations of albumin, IgG, IgM and IgA in the serum samples were measured by Kinetic nephelometry (Beckman Coulter IMMAGE, Brea, CA, USA) The following reference values for serum immunoglobulins were used: IgG ≥ 7 g/l, IgA ≥ 0.7 g/l, IgM ≥ 0.4 g/l [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>, <a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. Serum free light chains kappa were measured by nephelometry using the N Latex FLC kappa kit (Siemens Healthcare Diagnostics Products GmbH, Erlangen, Germany) according to the manufacturers protocol on the Atellica Neph 630 System (Siemens Healthcare Diagnostics Products GmbH, Erlangen, Germany). The serum pre-dilution was set to 1:100. The lower limit of quantification of the assay was 0.034 mg/l. According to the manufacturer, a reference concentration for serum KFLC ranging from 3.3 mg/l to 19.4 mg/l was considered [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. 8-color fluorescence-activated cell sorting (FACS) analyses were routinely performed in the Institute of Clinical Chemistry of Hannover Medical School as part of the routine work-up according to international guidelines [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>].</p></section><section id="Sec6"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par12">Statistical analysis was performed using GraphPad Prism (La Jolla, CA, USA; version 10.1.2). The statistical significance level was set at 5%. The D’Agostino &amp; Pearson omnibus normality test was used to assess the normal distribution of the values. Data were described as minimum, maximum (min-max) and mean unless otherwise stated. The Mann–Whitney U-test was used to analyze independent values. The Kruskal–Wallis test and the Friedman test with Dunn’s Multiple Comparison posthoc test were used for group comparison. Spearman’s r (Gaussian distributed values) and Pearson’s r (nonparametric distributed values) were used to test for correlation and the p-values and correlation coefficient (ρ) were presented.</p></section></section><section id="Sec7"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec8"><h3 class="pmc_sec_title">Patient characteristics</h3>
<p id="Par13">Of the included patients, 58% (29/50) were females with a predominance in the RMS group (RMS: 63%, 24/38; PPMS: 42%, 5/12) and a median age of 40 years in RMS and 45.5 in PPMS at initiation of ocrelizumab (Table <a href="#Tab1" class="usa-link">1</a>). Most of the RMS patients were already treated before initiation of ocrelizumab (71%, 27/38), with fumaric acids being the most prevalent previous DMT. As shown in Table <a href="#Tab1" class="usa-link">1</a> and supplemental Fig. <a href="#MOESM2" class="usa-link">1</a>, pathologically elevated serum KFLC concentrations or distinct renal function impairment (below an eGFR of 50 ml/min/1.73 m²) were not observed at any time point and a highly significant correlation between eGFR but not serum creatinine and serum KFLC was observed.</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Demographical and clinical data of multiple sclerosis patients</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">Total multiple sclerosis patients (<em>n</em> = 50)</th>
<th align="left" colspan="1" rowspan="1">Relapsing multiple sclerosis (<em>n</em> = 38)</th>
<th align="left" colspan="1" rowspan="1">Primary-progressive multiple sclerosis (<em>n</em> = 12)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Age in years, median (IQR)</td>
<td align="left" colspan="1" rowspan="1">41 (30–50)</td>
<td align="left" colspan="1" rowspan="1">40 (28–49)</td>
<td align="left" colspan="1" rowspan="1">45.5 (33–54)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Females, n (%)</td>
<td align="left" colspan="1" rowspan="1">29 (58%)</td>
<td align="left" colspan="1" rowspan="1">24 (63%)</td>
<td align="left" colspan="1" rowspan="1">5 (42%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Time since MS diagnosis [months], median (IQR)</td>
<td align="left" colspan="1" rowspan="1">34 (5-136)</td>
<td align="left" colspan="1" rowspan="1">29 (4-155)</td>
<td align="left" colspan="1" rowspan="1">63 (12–131)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Expanded disability status scale (EDSS) score, median (IQR)</td>
<td align="left" colspan="1" rowspan="1">3.5 (2-5.5)</td>
<td align="left" colspan="1" rowspan="1">2.5 (1.5-4)</td>
<td align="left" colspan="1" rowspan="1">5.5 (1.5-4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">C-reactive protein [mg/l], median (IQR)</td>
<td align="left" colspan="1" rowspan="1">0.75 (0.4-2)</td>
<td align="left" colspan="1" rowspan="1">0.95 (0.5–2.5)</td>
<td align="left" colspan="1" rowspan="1">0.5 (0.3–0.85)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Renal function estimated by eGFR (ml/min/1.73 m²) according to CKD-EPI equation, median (IQR)</td>
<td align="left" colspan="1" rowspan="1">100 (90–109)</td>
<td align="left" colspan="1" rowspan="1">102 (92–109)</td>
<td align="left" colspan="1" rowspan="1">94 (90–114)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Patients with preceding disease-modifying therapies within the last 12 months before initiation of ocrelizumab, n (%)</td>
<td align="left" colspan="1" rowspan="1">30 (60%)</td>
<td align="left" colspan="1" rowspan="1">27 (71%)</td>
<td align="left" colspan="1" rowspan="1">3 (25%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Preceding disease-modifying therapy with:</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Fumaric acids, n (%)</td>
<td align="left" colspan="1" rowspan="1">11/30 (37%)</td>
<td align="left" colspan="1" rowspan="1">10/27 (37%)</td>
<td align="left" colspan="1" rowspan="1">1/3 (33%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Glatirameracetate, n (%)</td>
<td align="left" colspan="1" rowspan="1">4/30 (13%)</td>
<td align="left" colspan="1" rowspan="1">4/27 (15%)</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Natalizumab, n (%)</td>
<td align="left" colspan="1" rowspan="1">4/30 (13%)</td>
<td align="left" colspan="1" rowspan="1">4/27 (15%)</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Fingolimod, n (%)</td>
<td align="left" colspan="1" rowspan="1">3/30 (10%)</td>
<td align="left" colspan="1" rowspan="1">3/27 (11%)</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Teriflunomide, n (%)</td>
<td align="left" colspan="1" rowspan="1">3/30 (10%)</td>
<td align="left" colspan="1" rowspan="1">2/27 (7%)</td>
<td align="left" colspan="1" rowspan="1">1/3 (33%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Interferons, n (%)</td>
<td align="left" colspan="1" rowspan="1">2/30 (7%)</td>
<td align="left" colspan="1" rowspan="1">2/27 (7%)</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Daclizumab, n (%)</td>
<td align="left" colspan="1" rowspan="1">2/30 (7%)</td>
<td align="left" colspan="1" rowspan="1">2/27 (7%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Quarterly intravenous mitoxantrone application, n (%)</td>
<td align="left" colspan="1" rowspan="1">1/30 (3%)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">1/3 (33%)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p18"><p>IQR = interquartile range</p></div></div></section></section></section><section id="Sec9"><h2 class="pmc_sec_title">The influence of Ocrelizumab treatment on KFLC, Immunoglobulins and leukocyte populations</h2>
<p id="Par15">Serum KFLC concentration decreased significantly after two years of ocrelizumab treatment compared to baseline concentration from a mean of 9.5 mg/l (± standard deviation (SD) 3.8) to 7.8 mg/l (± 3.8; <em>p</em> = 0.0003; Fig. <a href="#Fig1" class="usa-link">1</a>, A) with 4% (2/50) of patients presenting with concentration below the reference value of 3.3 mg/l (before treatment no patient was below 3.3 mg/l). Similar to KFLC concentration, concentration of all immunoglobulin classes was significantly lower after two years of ocrelizumab treatment (IgG: 9 g/l (± 2.2) vs. 8 g/l (± 2.2), <em>p</em> = 0.0002; IgA: 2 g/l (± 0.9) vs. 1.8 (± 1.0) g/l, <em>p</em> = 0.0010; IgM: 1.8 g/l (± 0.5) vs. 0.7 g/l (± 0.4), <em>p</em> &lt; 0.0001; Fig. <a href="#Fig1" class="usa-link">1</a>, B-D).</p>
<figure class="fig xbox font-sm" id="Fig1"><h3 class="obj_head">Fig. 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372195_42466_2025_419_Figa_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a1d/12372195/f2f5f5f3fb2a/42466_2025_419_Figa_HTML.jpg" loading="lazy" id="d33e693" height="519" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Comparison of kappa free light chain (KFLC) and immunoglobulin (Ig) G, A, and M concentrations at baseline and two years under ocrelizumab treatment. Depicted are KFLC <strong>(A)</strong>, IgG <strong>(B)</strong>, IgA <strong>(C)</strong> and IgM <strong>(D)</strong> concentrations in serum. The level of statistical significance is indicated above the line</p></figcaption></figure><p id="Par17">Furthermore, the percentage of patients with pathologically low serum Ig concentrations increased significantly after two years of ocrelizumab treatment, reaching statistical significance for IgG and IgM (IgG: 7/50 vs. 18/50, <em>p</em> = 0.0198; IgA: 0/50 vs. 4/50, <em>p</em> = 0.3839; IgM: 0/50 vs. 13/50, <em>p</em> &lt; 0.0001).</p>
<p id="Par18">While the total number of leukocytes remained unchanged, total lymphocyte count significantly decreased (Table <a href="#Tab2" class="usa-link">2</a>). The absolute numbers of neutrophile, eosinophile and basophile granulocytes remained unaffected, whereas the absolute monocyte count increased significantly after two years of ocrelizumab treatment (Table <a href="#Tab2" class="usa-link">2</a>). While CD20<sup>+</sup> and CD19<sup>+</sup> lymphocyte counts significantly decreased, CD3<sup>+</sup> lymphocyte counts remained unchanged and CD56<sup>+</sup> lymphocytes significantly increased (Table <a href="#Tab2" class="usa-link">2</a>).</p>
<section class="tw xbox font-sm" id="Tab2"><h3 class="obj_head">Table 2.</h3>
<div class="caption p"><p>Flow cytometric and laboratory analysis data of multiple sclerosis (MS) patients</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">Baseline,<br><em>n</em> = 50</th>
<th align="left" colspan="1" rowspan="1">Two years after treatment onset (after infusion of 2400 mg ocrelizumab), <br><em>n</em> = 50</th>
<th align="left" colspan="1" rowspan="1">
<em>p</em>-value</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Leukocytes [absolute count, thousand/µl], mean (SD)</td>
<td align="center" colspan="1" rowspan="1">7.0 (2.09)</td>
<td align="center" colspan="1" rowspan="1">7.1 (2.52)</td>
<td align="center" colspan="1" rowspan="1">0.9662</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Lymphocytes [absolute count, thousand/µl], mean (SD)</td>
<td align="center" colspan="1" rowspan="1">1.89 (0.83)</td>
<td align="center" colspan="1" rowspan="1">1.59 (0.53)</td>
<td align="center" colspan="1" rowspan="1">
<strong>0.0179</strong>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Neutrophile granulocytes [absolute count, thousand/µl], mean (SD)</td>
<td align="center" colspan="1" rowspan="1">4.3 (1.82)</td>
<td align="center" colspan="1" rowspan="1">4.7 (2.59)</td>
<td align="center" colspan="1" rowspan="1">0.4032</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Eosinophile granulocytes [absolute count, thousand/µl], mean (SD)</td>
<td align="center" colspan="1" rowspan="1">0.15 (0.12)</td>
<td align="center" colspan="1" rowspan="1">0.19 (0.24)</td>
<td align="center" colspan="1" rowspan="1">0.3008</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Basophile granulocytes [absolute count, thousand/µl], mean (SD)</td>
<td align="center" colspan="1" rowspan="1">0.05 (0.03)</td>
<td align="center" colspan="1" rowspan="1">0.08 (0.1)</td>
<td align="center" colspan="1" rowspan="1">0.0686</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Monocytes [absolute count, thousand/µl], mean (SD)</td>
<td align="center" colspan="1" rowspan="1">0.56 (0.19)</td>
<td align="center" colspan="1" rowspan="1">0.67 (0.21)</td>
<td align="center" colspan="1" rowspan="1">
<strong>0.0028</strong>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD20<sup>+</sup> lymphocytes [absolute count, thousand/µl], mean (SD)</td>
<td align="center" colspan="1" rowspan="1">0.19 (0.11)</td>
<td align="center" colspan="1" rowspan="1">0.003 (0.015)</td>
<td align="center" colspan="1" rowspan="1">
<strong>&lt; 0.0001</strong>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD19<sup>+</sup> lymphocytes [absolute count, thousand/µl], mean (SD)</td>
<td align="center" colspan="1" rowspan="1">0.19 (0.11)</td>
<td align="center" colspan="1" rowspan="1">0.003 (0.015)</td>
<td align="center" colspan="1" rowspan="1">
<strong>&lt; 0.0001</strong>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD3<sup>+</sup> lymphocytes [absolute count, thousand/µl], mean (SD)</td>
<td align="center" colspan="1" rowspan="1">1.37 (0.45)</td>
<td align="center" colspan="1" rowspan="1">1.33 (0.49)</td>
<td align="center" colspan="1" rowspan="1">0.8610</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD56<sup>+</sup> lymphocytes [absolute count, thousand/µl], mean (SD)</td>
<td align="center" colspan="1" rowspan="1">0.23 (0.12)</td>
<td align="center" colspan="1" rowspan="1">0.27 (0.15)</td>
<td align="center" colspan="1" rowspan="1">
<strong>0.0194</strong>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p26"><p>SD = standard deviation</p></div></div></section><section id="Sec10"><h3 class="pmc_sec_title">Serum KFLC concentration cannot predict disease activity during ocrelizumab treatment</h3>
<p id="Par20">Relapses and/or PIRA occurred in 22% (11/50) of patients (3 PPMS, 8 RMS) during the 2-year treatment period. 10/11 patients (2 PPMS, 8 RMS) received intravenous corticosteroids of which 7 (3 PPMS, 4 RMS) fully recovered. Overall, the median EDSS score was stable compared with baseline (3.5 and 3.0 respectively, <em>p</em> = 0.6068). In five patients, an EDSS score reduction between 0.5 and 1.5 points was observed while EDSS score rose in seven patients (between 0.5 and 2.0 points). Furthermore, 80% (40/50) of patients were able to perform walking tests. A worsening in the T25FWT of at least 20% was found in 14/40 patients when baseline time and time after two years of ocrelizumab treatment were compared (median worsening of 18 s (interquartile range: 14–88 s). MS disease activity in MRI was found in 12% (6/50) of patients with a total of eight new T2 lesions.</p>
<p id="Par21">Comparison of baseline serum KFLC concentration of patients with and without disease exacerbation with regard to clinical (relapses, PIRA, EDSS worsening) or MRI-morphological (new T2 lesions) disease activity revealed no statistically significant differences (<em>p</em> = 0.1724, <em>p</em> = 0.1647, respectively). KFLC concentration did not differ significantly in patients with increasing EDSS compared to patients with improved or stable EDSS after two years of ocrelizumab treatment (<em>p</em> = 0.7977). For T25FWT, no statistically significant differences concerning serum KFLC concentration between patient samples with and without worsening were found (<em>p</em> = 0.5392).</p></section><section id="Sec11"><h3 class="pmc_sec_title">Serum KFLC correlate with IgG and IgA concentrations</h3>
<p id="Par22">Analysis of serum KFLC concentration at baseline and after two years of ocrelizumab treatment with serum IgG and IgA concentrations revealed a significant correlation and significant linear regression as shown in Fig. <a href="#Fig2" class="usa-link">2</a>, A and B. A correlation or significant linear regression did not exist between serum KFLC and IgM concentration (Fig. <a href="#Fig2" class="usa-link">2</a>, C). Serum KFLC concentration and the percentage of CD20<sup>+</sup> lymphocytes showed a significant correlation (Fig. <a href="#Fig2" class="usa-link">2</a>D).</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372195_42466_2025_419_Figb_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a1d/12372195/5e890363e9b3/42466_2025_419_Figb_HTML.jpg" loading="lazy" id="d33e943" height="538" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Correlations of kappa free light chain (KFLC) concentration. Depicted are correlations of serum KFLC concentration with immunoglobulin (Ig) G <strong>(A)</strong>, A <strong>(B)</strong> and M <strong>(C)</strong> concentrations and the absolute cell count of CD20<sup>+</sup> lymphocytes <strong>(D)</strong>. The level of statistical significance of the linear regression and the correlation are given as well as the coefficient of correlation (ρ)</p></figcaption></figure></section></section><section id="Sec12"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par24">Depletion of CD20<sup>+</sup> lymphocytes with ocrelizumab has been shown to be effective in the treatment of RMS and PPMS patients. Since CD20<sup>+</sup> T and B cells are targeted by ocrelizumab treatment, markers of B cell activity in serum including KFLC, immunoglobulins, as well as lymphocyte subsets were investigated in the present study. In addition, this is the first study to evaluate serum KFLC concentrations for their potential as a biomarker for treatment monitoring in MS.</p>
<p id="Par25">Investigation of clinical and imaging parameters for disease activity did not reveal any significant group differences or correlations with the serum KFLC concentration, indicating the missing capability of KFLC to monitor disease activity under ocrelizumab treatment in the present study. Nevertheless, a significant decrease of serum Ig and KFLC concentrations under ocrelizumab treatment over a time period of two years was observed. Since B cells, which are the origin of these proteins, are effectively depleted under ocrelizumab treatment, a reduction was expectable. This finding is also underlined by the positive correlation between serum KFLC concentration and Ig concentrations as well as CD20<sup>+</sup> lymphocyte count. However, since many data points of the amount of CD20<sup>+</sup> lymphocytes clustered near zero on the x-axis, the interpretability of this correlation is limited despite being statistically significant. Interestingly, no correlation was found between IgM and KFLC concentrations in serum. Possible explanations for this phenomenon include different originating cell types of IgM antibodies (naïve B cells) and KFLC (long-living plasma cells) and their different affection by anti-CD20-therapies (targeting long-living plasma cells to a lesser proportion), the lower excessive synthesis of KFLC in the formation of the pentamer IgM antibodies, the different half-life time of KFLC (hours) and IgM antibodies (several days) due to the different molecular weight, and lastly the dominance of IgG and IgA in chronic polyclonal immune activation in autoimmune diseases such as MS [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>, <a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>, <a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>–<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. The combination of these mechanisms could lead to a decoupling of IgM and KFLC concentrations in serum and therefore the observed missing correlation. Contrarily, the cross-sectional study of Süße et al. did not report of significant concentration differences in serum between patients taking high effective DMT, moderately effective DMT and no DMT [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. A possible explanation might be that the time period under treatment of the included patients in the very high effective DMT cohort was rather short (median 88 days), thus significant differences in serum concentration compared with treatment-naïve patients might not have been found at that early time point [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. In addition, the high effective DMT cohort did not only include patients under CD20-depleting therapies but also other DMT, which not primarily target B cells [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>].</p>
<p id="Par26">Furthermore, interpreting KFLC concentration, renal function impairment as possible cause for pathologically elevated serum KFLC concentration as well as an increased synthesis of KFLC should be considered [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>, <a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. In the present study, pathologically elevated serum KFLC concentrations at baseline as well as distinct renal function impairment were not observed.</p>
<p id="Par27">Lastly, the role of serum KFLC as possible predictors for disease progression in MS or conversion from clinically isolated syndrome to MS was not investigated yet. In contrast to serum concentrations, the prediction of disease and disability progression based on KFLC concentration in CSF has been extensively studied, yielding conflicting results [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>, <a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>, <a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. Some studies found a significant correlation between high KFLC concentration in CSF and early disability or disability progression, which was mainly estimated by EDSS in patients with RRMS [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>–<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]. Berek and colleagues reported that a high KFLC index (&gt; 100) at baseline was associated with a shorter time to clinically definite MS and a higher risk of a second clinical relapse within 24 months from baseline [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. In contrast, other studies have failed to find a correlation between disease progression as measured by EDSS and KFLC concentration in CSF or KFLC indices [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>–<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]. Reports in the literature are also quite heterogeneous regarding the correlation of KFLC in CSF with MRI parameters of CNS inflammation [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Some studies have reported significant correlations between elevated KFLC concentration in CSF or KFLC indices and brain atrophy, brain lesion pattern, or T2-lesion volume in MS patients [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>, <a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>, <a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>]. In contrast, other studies have not found a significant association between KFLC and brain damage according to MRI or the localization and load of MRI abnormalities [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>, <a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]. Since this is the first study to investigate the association between MS disease activity and serum KFLC concentrations, no data are yet available to enlighten this issue. In the present study, serum KFLC concentration did not appear to be a suitable biomarker for disease or treatment monitoring, since no correlation with clinical or imaging signs for disease activity was observed. In general, the missing association of serum KFLC with MS disease activity, even under B cell targeting anti-CD20 therapy, might be due to the reflection of a broader, polyclonal, and systemic immune action of serum KFLC, which not necessarily and specifically mirrors the compartmentalized auto-inflammatory processes in the CNS, which are characteristic for MS [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. This is in contrast to systemic autoimmune diseases such as rheumatoid arthritis or Sjögren´s disease, in which there was a correlation between reduction of KFLC in serum and disease activity under treatment with anti-CD20 therapy with rituximab [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Although in our study a higher than expected rate of patients with disease activity of about 20% was observed, the limitation of the low number of included patients, and the inclusion of both, RMS and PPMS patients leading to missing feasibility of subgroup analyses, might be another explanatory factor for the lacking associations between MS disease activity and serum KFLC concentrations. Lastly, the serum samples investigated in our study were not obtained at the time point of the disease activity. For example, none of the samples from patients with relapsing disease activity were gained at the time point of the relapse, but at year two under treatment with ocrelizumab. Therefore, associations between relapsing disease activity in MS and serum KFLC concentrations might be found, when samples are investigated, which were gained at the onset of the new symptoms.</p></section><section id="Sec13"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par28">Infusion of the anti-CD20 monoclonal antibody ocrelizumab resulted in effective depletion of CD20<sup>+</sup> lymphocytes and a consecutive decrease in serum KFLC levels. The reduced serum KFLC levels were not able to predict disease activity in these MS patients.</p></section><section id="Sec14"><h2 class="pmc_sec_title">Supplementary Information</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12372195/bin/42466_2025_419_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (12.6KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12372195/bin/42466_2025_419_MOESM2_ESM.jpg" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 2</a><sup> (55KB, jpg) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>The authors would like to thank Karin Fricke, Kathrin Scheiwe, Sabine Lang, Katharina Dorsch, and Ilona Cierpka-Leja for excellent technical assistance.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Conceptualization, FFK, TS, SG; methodology, FFK, TS, PS; formal analysis, FFK, GMK, TS; data curation, FFK, PSG, SG, GMK, KFJ; writing—original draft preparation, FFK, TS, SG; writing—review and editing, GMK, PSG, MWH, PS, KFJ, SN, NM, LGL, KWS, EV, RP, TW.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>Open Access funding enabled and organized by Projekt DEAL. This research received no external funding.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par29">The investigation was approved by the Ethics Committee of MHH (8787_BO_K_2019) and followed the rules of the Declaration of Helsinki of 1964 and its later amendments. Informed consent for participation was obtained from all subjects involved in the study.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par30">Informed consent for publication was obtained from all subjects involved in the study.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par31">The authors declare no conflict of interest. Outside the submitted work, some authors received honoraria for lectures, travel grants, or research grants.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Hutchison, C. A., Basnayake, K., &amp; Cockwell, P. (2009). Serum free light chain assessment in monoclonal gammopathy and kidney disease. <em>Nature Reviews Nephrology</em>, <em>5</em>(11), 621–628. 10.1038/nrneph.2009.151
</cite> [<a href="https://doi.org/10.1038/nrneph.2009.151" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19786994/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hutchison,%20C.%20A.,%20Basnayake,%20K.,%20&amp;%20Cockwell,%20P.%20(2009).%20Serum%20free%20light%20chain%20assessment%20in%20monoclonal%20gammopathy%20and%20kidney%20disease.%20Nature%20Reviews%20Nephrology,%205(11),%20621%E2%80%93628.%2010.1038/nrneph.2009.151" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Konen, F. F., Wurster, U., Schwenkenbecher, P., Gerritzen, A., Groß, C. C., Eichhorn, P., Harrer, A., Isenmann, S., Lewczuk, P., Lewerenz, J., Leypoldt, F., Otto, M., Regeniter, A., Roskos, M., Ruprecht, K., Spreer, A., Strik, H., Uhr, M., Wick, M., Wildemann, B., Wiltfang, J., Zimmermann, T., Hannich, M., Khalil, M., Tumani, H., Süße, M., Skripuletz, T., &amp; German Society for Cerebrospinal Fluid Diagnostics and Clinical Neurochemistry (DGLN e.V.). (2025). Oligoclonal bands and kappa free light chains: Competing parameters or complementary biomarkers? <em>Autoimmunity Reviews</em>, <em>24</em>(5), 103765. 10.1016/j.autrev.2025.103765
</cite> [<a href="https://doi.org/10.1016/j.autrev.2025.103765" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39947571/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Konen,%20F.%20F.,%20Wurster,%20U.,%20Schwenkenbecher,%20P.,%20Gerritzen,%20A.,%20Gro%C3%9F,%20C.%20C.,%20Eichhorn,%20P.,%20Harrer,%20A.,%20Isenmann,%20S.,%20Lewczuk,%20P.,%20Lewerenz,%20J.,%20Leypoldt,%20F.,%20Otto,%20M.,%20Regeniter,%20A.,%20Roskos,%20M.,%20Ruprecht,%20K.,%20Spreer,%20A.,%20Strik,%20H.,%20Uhr,%20M.,%20Wick,%20M.,%20Wildemann,%20B.,%20Wiltfang,%20J.,%20Zimmermann,%20T.,%20Hannich,%20M.,%20Khalil,%20M.,%20Tumani,%20H.,%20S%C3%BC%C3%9Fe,%20M.,%20Skripuletz,%20T.,%20&amp;%20German%20Society%20for%20Cerebrospinal%20Fluid%20Diagnostics%20and%20Clinical%20Neurochemistry%20(DGLN%20e.V.).%20(2025).%20Oligoclonal%20bands%20and%20kappa%20free%20light%20chains:%20Competing%20parameters%20or%20complementary%20biomarkers?%20Autoimmunity%20Reviews,%2024(5),%20103765.%2010.1016/j.autrev.2025.103765" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Gottenberg, J. E., Aucouturier, F., Goetz, J., Sordet, C., Jahn, I., Busson, M., Cayuela, J. M., Sibilia, J., &amp; Mariette, X. (2007). Serum Immunoglobulin free light chain assessment in rheumatoid arthritis and primary sjogren’s syndrome. <em>Annals of the Rheumatic Diseases</em>, <em>66</em>(1), 23–27. 10.1136/ard.2006.052159
</cite> [<a href="https://doi.org/10.1136/ard.2006.052159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1798389/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16569685/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gottenberg,%20J.%20E.,%20Aucouturier,%20F.,%20Goetz,%20J.,%20Sordet,%20C.,%20Jahn,%20I.,%20Busson,%20M.,%20Cayuela,%20J.%20M.,%20Sibilia,%20J.,%20&amp;%20Mariette,%20X.%20(2007).%20Serum%20Immunoglobulin%20free%20light%20chain%20assessment%20in%20rheumatoid%20arthritis%20and%20primary%20sjogren%E2%80%99s%20syndrome.%20Annals%20of%20the%20Rheumatic%20Diseases,%2066(1),%2023%E2%80%9327.%2010.1136/ard.2006.052159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Ye, Y., Li, S. L., Xie, M., Jiang, P., Liu, K. G., &amp; Li, Y. J. (2013). Judging disease activity in rheumatoid arthritis by serum free kappa and lambda light chain levels. <em>The Kaohsiung Journal of Medical Sciences</em>, <em>29</em>(10), 547–553. 10.1016/j.kjms.2013.01.013
</cite> [<a href="https://doi.org/10.1016/j.kjms.2013.01.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11916879/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24099109/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ye,%20Y.,%20Li,%20S.%20L.,%20Xie,%20M.,%20Jiang,%20P.,%20Liu,%20K.%20G.,%20&amp;%20Li,%20Y.%20J.%20(2013).%20Judging%20disease%20activity%20in%20rheumatoid%20arthritis%20by%20serum%20free%20kappa%20and%20lambda%20light%20chain%20levels.%20The%20Kaohsiung%20Journal%20of%20Medical%20Sciences,%2029(10),%20547%E2%80%93553.%2010.1016/j.kjms.2013.01.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Kaplan, B., Livneh, A., &amp; Sela, B. A. (2011). Immunoglobulin free light chain dimers in human diseases. <em>TheScientificWorldJournal</em>, <em>11</em>, 726–735. 10.1100/tsw.2011.65
</cite> [<a href="https://doi.org/10.1100/tsw.2011.65" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5720091/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21442150/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kaplan,%20B.,%20Livneh,%20A.,%20&amp;%20Sela,%20B.%20A.%20(2011).%20Immunoglobulin%20free%20light%20chain%20dimers%20in%20human%20diseases.%20TheScientificWorldJournal,%2011,%20726%E2%80%93735.%2010.1100/tsw.2011.65" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Kormelink, T. G., Tekstra, J., Thurlings, R. M., Boumans, M. H., Vos, K., Tak, P. P., Bijlsma, J. W., Lafeber, F. P., Redegeld, F. A., &amp; van Roon, J. A. (2010). Decrease in Immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity. <em>Annals of the Rheumatic Diseases</em>, <em>69</em>(12), 2137–2144. 10.1136/ard.2009.126441
</cite> [<a href="https://doi.org/10.1136/ard.2009.126441" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20679475/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kormelink,%20T.%20G.,%20Tekstra,%20J.,%20Thurlings,%20R.%20M.,%20Boumans,%20M.%20H.,%20Vos,%20K.,%20Tak,%20P.%20P.,%20Bijlsma,%20J.%20W.,%20Lafeber,%20F.%20P.,%20Redegeld,%20F.%20A.,%20&amp;%20van%20Roon,%20J.%20A.%20(2010).%20Decrease%20in%20Immunoglobulin%20free%20light%20chains%20in%20patients%20with%20rheumatoid%20arthritis%20upon%20rituximab%20(anti-CD20)%20treatment%20correlates%20with%20decrease%20in%20disease%20activity.%20Annals%20of%20the%20Rheumatic%20Diseases,%2069(12),%202137%E2%80%932144.%2010.1136/ard.2009.126441" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Verstappen, G. M., Moerman, R. V., van Nimwegen, J. F., van Ginkel, M. S., Bijzet, J., Mossel, E., Vissink, A., Hazenberg, B. P. C., Arends, S., Kroese, F. G. M., &amp; Bootsma, H. (2018). Serum Immunoglobulin free light chains are sensitive biomarkers for monitoring disease activity and treatment response in primary sjögren’s syndrome. <em>Rheumatology (Oxford England)</em>, <em>57</em>(10), 1812–1821. 10.1093/rheumatology/key180
</cite> [<a href="https://doi.org/10.1093/rheumatology/key180" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29982712/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Verstappen,%20G.%20M.,%20Moerman,%20R.%20V.,%20van%20Nimwegen,%20J.%20F.,%20van%20Ginkel,%20M.%20S.,%20Bijzet,%20J.,%20Mossel,%20E.,%20Vissink,%20A.,%20Hazenberg,%20B.%20P.%20C.,%20Arends,%20S.,%20Kroese,%20F.%20G.%20M.,%20&amp;%20Bootsma,%20H.%20(2018).%20Serum%20Immunoglobulin%20free%20light%20chains%20are%20sensitive%20biomarkers%20for%20monitoring%20disease%20activity%20and%20treatment%20response%20in%20primary%20sj%C3%B6gren%E2%80%99s%20syndrome.%20Rheumatology%20(Oxford%20England),%2057(10),%201812%E2%80%931821.%2010.1093/rheumatology/key180" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Montalban, X. (2024). 2024 revisions of the McDonald criteria. ECTRIMS: 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, 18–20 September 2024. <a href="https://ectrims.eu/mcdonald-diagnostic-criteria" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://ectrims.eu/mcdonald-diagnostic-criteria</a>. Accessed 5 November 2024.</cite>
</li>
<li id="CR9">
<span class="label">9.</span><cite>Cencioni, M. T., Mattoscio, M., Magliozzi, R., Bar-Or, A., &amp; Muraro, P. A. (2021). B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies. <em>Nature Reviews Neurology</em>, <em>17</em>(7), 399–414. 10.1038/s41582-021-00498-5
</cite> [<a href="https://doi.org/10.1038/s41582-021-00498-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34075251/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cencioni,%20M.%20T.,%20Mattoscio,%20M.,%20Magliozzi,%20R.,%20Bar-Or,%20A.,%20&amp;%20Muraro,%20P.%20A.%20(2021).%20B%20cells%20in%20multiple%20sclerosis%20-%20from%20targeted%20depletion%20to%20immune%20reconstitution%20therapies.%20Nature%20Reviews%20Neurology,%2017(7),%20399%E2%80%93414.%2010.1038/s41582-021-00498-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Süße, M., Hannich, M., Petersmann, A., Zylla, S., Pietzner, M., Nauck, M., &amp; Dressel, A. (2018). Kappa free light chains in cerebrospinal fluid to identify patients with oligoclonal bands. <em>European Journal of Neurology</em>, <em>25</em>(9), 1134–1139. 10.1111/ene.13667
</cite> [<a href="https://doi.org/10.1111/ene.13667" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29683546/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?S%C3%BC%C3%9Fe,%20M.,%20Hannich,%20M.,%20Petersmann,%20A.,%20Zylla,%20S.,%20Pietzner,%20M.,%20Nauck,%20M.,%20&amp;%20Dressel,%20A.%20(2018).%20Kappa%20free%20light%20chains%20in%20cerebrospinal%20fluid%20to%20identify%20patients%20with%20oligoclonal%20bands.%20European%20Journal%20of%20Neurology,%2025(9),%201134%E2%80%931139.%2010.1111/ene.13667" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Nakano, T., Matsui, M., Inoue, I., Awata, T., Katayama, S., &amp; Murakoshi, T. (2011). Free Immunoglobulin light chain: Its biology and implications in diseases. <em>Clinica Chimica Acta; International Journal of Clinical Chemistry</em>, <em>412</em>(11–12), 843–849. 10.1016/j.cca.2011.03.007
</cite> [<a href="https://doi.org/10.1016/j.cca.2011.03.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21396928/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nakano,%20T.,%20Matsui,%20M.,%20Inoue,%20I.,%20Awata,%20T.,%20Katayama,%20S.,%20&amp;%20Murakoshi,%20T.%20(2011).%20Free%20Immunoglobulin%20light%20chain:%20Its%20biology%20and%20implications%20in%20diseases.%20Clinica%20Chimica%20Acta;%20International%20Journal%20of%20Clinical%20Chemistry,%20412(11%E2%80%9312),%20843%E2%80%93849.%2010.1016/j.cca.2011.03.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Schwenkenbecher, P., Konen, F. F., Wurster, U., Witte, T., Gingele, S., Sühs, K. W., Stangel, M., &amp; Skripuletz, T. (2019). Reiber’s diagram for kappa free light chains: The new standard for assessing intrathecal synthesis?? <em>Diagnostics (Basel Switzerland)</em>, <em>9</em>(4), 194. 10.3390/diagnostics9040194
</cite> [<a href="https://doi.org/10.3390/diagnostics9040194" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6963502/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31744096/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schwenkenbecher,%20P.,%20Konen,%20F.%20F.,%20Wurster,%20U.,%20Witte,%20T.,%20Gingele,%20S.,%20S%C3%BChs,%20K.%20W.,%20Stangel,%20M.,%20&amp;%20Skripuletz,%20T.%20(2019).%20Reiber%E2%80%99s%20diagram%20for%20kappa%20free%20light%20chains:%20The%20new%20standard%20for%20assessing%20intrathecal%20synthesis??%20Diagnostics%20(Basel%20Switzerland),%209(4),%20194.%2010.3390/diagnostics9040194" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Topping, J., Dobson, R., Lapin, S., Maslyanskiy, A., Kropshofer, H., Leppert, D., Giovannoni, G., &amp; Evdoshenko, E. (2016). The effects of intrathecal rituximab on biomarkers in multiple sclerosis. <em>Multiple Sclerosis and Related Disorders</em>, <em>6</em>, 49–53. 10.1016/j.msard.2016.01.001
</cite> [<a href="https://doi.org/10.1016/j.msard.2016.01.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27063622/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Topping,%20J.,%20Dobson,%20R.,%20Lapin,%20S.,%20Maslyanskiy,%20A.,%20Kropshofer,%20H.,%20Leppert,%20D.,%20Giovannoni,%20G.,%20&amp;%20Evdoshenko,%20E.%20(2016).%20The%20effects%20of%20intrathecal%20rituximab%20on%20biomarkers%20in%20multiple%20sclerosis.%20Multiple%20Sclerosis%20and%20Related%20Disorders,%206,%2049%E2%80%9353.%2010.1016/j.msard.2016.01.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Rosenstein, I., Rasch, S., Axelsson, M., Novakova, L., Blennow, K., Zetterberg, H., &amp; Lycke, J. (2021). Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real-world investigation. <em>Journal of Neurochemistry</em>, <em>159</em>(3), 618–628. 10.1111/jnc.15500
</cite> [<a href="https://doi.org/10.1111/jnc.15500" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34478561/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rosenstein,%20I.,%20Rasch,%20S.,%20Axelsson,%20M.,%20Novakova,%20L.,%20Blennow,%20K.,%20Zetterberg,%20H.,%20&amp;%20Lycke,%20J.%20(2021).%20Kappa%20free%20light%20chain%20index%20as%20a%20diagnostic%20biomarker%20in%20multiple%20sclerosis:%20A%20real-world%20investigation.%20Journal%20of%20Neurochemistry,%20159(3),%20618%E2%80%93628.%2010.1111/jnc.15500" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Rudick, R. A., Cookfair, D. L., Simonian, N. A., Ransohoff, R. M., Richert, J. R.,Jacobs, L. D., Herndon, R. M., Salazar, A. M., Fischer, J. S., Granger, C. V., Goodkin,D. E., Simon, J. H., Bartoszak, D. M., Bourdette, D. N., Braiman, J., Brownscheidle,C. M., Coats, M. E., Cohan, S. L., Dougherty, D. S., Kinkel, R. P., … Whitham, R.H. (1999). Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a)for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.<em>Journal of neuroimmunology</em>, <em>93</em>(1–2), 8–14. 10.1016/s0165-5728(98)00174-x.</cite> [<a href="https://doi.org/10.1016/s0165-5728(98)00174-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10378864/" class="usa-link">PubMed</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Süße, M., Konen, F. F., Schwenkenbecher, P., Budde, K., Nauck, M., Grothe, M., Hannich, M. J., &amp; Skripuletz, T. (2022). Decreased intrathecal concentrations of free light chains kappa in multiple sclerosis patients taking very high effective Disease-Modifying treatment. <em>Diagnostics (Basel Switzerland)</em>, <em>12</em>(3), 720. 10.3390/diagnostics12030720
</cite> [<a href="https://doi.org/10.3390/diagnostics12030720" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8947149/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35328273/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?S%C3%BC%C3%9Fe,%20M.,%20Konen,%20F.%20F.,%20Schwenkenbecher,%20P.,%20Budde,%20K.,%20Nauck,%20M.,%20Grothe,%20M.,%20Hannich,%20M.%20J.,%20&amp;%20Skripuletz,%20T.%20(2022).%20Decreased%20intrathecal%20concentrations%20of%20free%20light%20chains%20kappa%20in%20multiple%20sclerosis%20patients%20taking%20very%20high%20effective%20Disease-Modifying%20treatment.%20Diagnostics%20(Basel%20Switzerland),%2012(3),%20720.%2010.3390/diagnostics12030720" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Konen, F. F., Wurster, U., Witte, T., Jendretzky, K. F., Gingele, S., Tumani, H., Sühs, K. W., Stangel, M., Schwenkenbecher, P., &amp; Skripuletz, T. (2020). The impact of Immunomodulatory treatment on kappa free light chains as biomarker in neuroinflammation. <em>Cells</em>, <em>9</em>(4), 842. 10.3390/cells9040842
</cite> [<a href="https://doi.org/10.3390/cells9040842" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7226742/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32244362/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Konen,%20F.%20F.,%20Wurster,%20U.,%20Witte,%20T.,%20Jendretzky,%20K.%20F.,%20Gingele,%20S.,%20Tumani,%20H.,%20S%C3%BChs,%20K.%20W.,%20Stangel,%20M.,%20Schwenkenbecher,%20P.,%20&amp;%20Skripuletz,%20T.%20(2020).%20The%20impact%20of%20Immunomodulatory%20treatment%20on%20kappa%20free%20light%20chains%20as%20biomarker%20in%20neuroinflammation.%20Cells,%209(4),%20842.%2010.3390/cells9040842" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Vecchio, D., Bellomo, G., Serino, R., Virgilio, E., Lamonaca, M., Dianzani, U., Cantello, R., Comi, C., &amp; Crespi, I. (2020). Intrathecal kappa free light chains as markers for multiple sclerosis. <em>Scientific Reports</em>, <em>10</em>(1), 20329. 10.1038/s41598-020-77029-7
</cite> [<a href="https://doi.org/10.1038/s41598-020-77029-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7683527/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33230241/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vecchio,%20D.,%20Bellomo,%20G.,%20Serino,%20R.,%20Virgilio,%20E.,%20Lamonaca,%20M.,%20Dianzani,%20U.,%20Cantello,%20R.,%20Comi,%20C.,%20&amp;%20Crespi,%20I.%20(2020).%20Intrathecal%20kappa%20free%20light%20chains%20as%20markers%20for%20multiple%20sclerosis.%20Scientific%20Reports,%2010(1),%2020329.%2010.1038/s41598-020-77029-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Hauser, S. L., Bar-Or, A., Comi, G., Giovannoni, G., Hartung, H. P., Hemmer, B.,Lublin, F., Montalban, X., Rammohan, K. W., Selmaj, K., Traboulsee, A., Wolinsky,J. S., Arnold, D. L., Klingelschmitt, G., Masterman, D., Fontoura, P., Belachew, S.,Chin, P., Mairon, N., Garren, H., … OPERA I and OPERA II Clinical Investigators (2017).Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis. <em>The New England journal of medicine</em>, <em>376</em>(3), 221–234. 10.1056/NEJMoa1601277.</cite> [<a href="https://doi.org/10.1056/NEJMoa1601277" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28002679/" class="usa-link">PubMed</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Montalban, X., Hauser, S. L., Kappos, L., Arnold, D. L., Bar-Or, A., Comi, G., de Seze, J., Giovannoni, G., Hartung, H. P., Hemmer, B., Lublin, F., Rammohan, K. W., Selmaj, K., Traboulsee, A., Sauter, A., Masterman, D., Fontoura, P., Belachew, S., Garren, H., Mairon, N., &amp; ORATORIO Clinical Investigators. (2017). Ocrelizumab versus placebo in primary progressive multiple sclerosis. <em>The New England Journal of Medicine</em>, <em>376</em>(3), 209–220. 10.1056/NEJMoa1606468
</cite> [<a href="https://doi.org/10.1056/NEJMoa1606468" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28002688/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Montalban,%20X.,%20Hauser,%20S.%20L.,%20Kappos,%20L.,%20Arnold,%20D.%20L.,%20Bar-Or,%20A.,%20Comi,%20G.,%20de%20Seze,%20J.,%20Giovannoni,%20G.,%20Hartung,%20H.%20P.,%20Hemmer,%20B.,%20Lublin,%20F.,%20Rammohan,%20K.%20W.,%20Selmaj,%20K.,%20Traboulsee,%20A.,%20Sauter,%20A.,%20Masterman,%20D.,%20Fontoura,%20P.,%20Belachew,%20S.,%20Garren,%20H.,%20Mairon,%20N.,%20&amp;%20ORATORIO%20Clinical%20Investigators.%20(2017).%20Ocrelizumab%20versus%20placebo%20in%20primary%20progressive%20multiple%20sclerosis.%20The%20New%20England%20Journal%20of%20Medicine,%20376(3),%20209%E2%80%93220.%2010.1056/NEJMoa1606468" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Gingele, S., Jacobus, T. L., Konen, F. F., Hümmert, M. W., Sühs, K. W., Schwenkenbecher, P., Ahlbrecht, J., Möhn, N., Müschen, L. H., Bönig, L., Alvermann, S., Schmidt, R. E., Stangel, M., Jacobs, R., &amp; Skripuletz, T. (2018). Ocrelizumab depletes CD20⁺ T cells in multiple sclerosis patients. <em>Cells</em>, <em>8</em>(1), 12. 10.3390/cells8010012
</cite> [<a href="https://doi.org/10.3390/cells8010012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6356421/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30597851/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gingele,%20S.,%20Jacobus,%20T.%20L.,%20Konen,%20F.%20F.,%20H%C3%BCmmert,%20M.%20W.,%20S%C3%BChs,%20K.%20W.,%20Schwenkenbecher,%20P.,%20Ahlbrecht,%20J.,%20M%C3%B6hn,%20N.,%20M%C3%BCschen,%20L.%20H.,%20B%C3%B6nig,%20L.,%20Alvermann,%20S.,%20Schmidt,%20R.%20E.,%20Stangel,%20M.,%20Jacobs,%20R.,%20&amp;%20Skripuletz,%20T.%20(2018).%20Ocrelizumab%20depletes%20CD20%E2%81%BA%20T%20cells%20in%20multiple%20sclerosis%20patients.%20Cells,%208(1),%2012.%2010.3390/cells8010012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Freeman, S. A., Lemarchant, B., Alberto, T., Boucher, J., Outteryck, O., Labalette, M., Rogeau, S., Dubucquoi, S., &amp; Zéphir, H. (2023). Assessing sustained B-Cell depletion and disease activity in a French multiple sclerosis cohort treated by Long-Term IV Anti-CD20 antibody therapy. <em>Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics</em>, <em>20</em>(6), 1707–1722. 10.1007/s13311-023-01446-5
</cite> [<a href="https://doi.org/10.1007/s13311-023-01446-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10684468/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37882961/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Freeman,%20S.%20A.,%20Lemarchant,%20B.,%20Alberto,%20T.,%20Boucher,%20J.,%20Outteryck,%20O.,%20Labalette,%20M.,%20Rogeau,%20S.,%20Dubucquoi,%20S.,%20&amp;%20Z%C3%A9phir,%20H.%20(2023).%20Assessing%20sustained%20B-Cell%20depletion%20and%20disease%20activity%20in%20a%20French%20multiple%20sclerosis%20cohort%20treated%20by%20Long-Term%20IV%20Anti-CD20%20antibody%20therapy.%20Neurotherapeutics:%20the%20Journal%20of%20the%20American%20Society%20for%20Experimental%20NeuroTherapeutics,%2020(6),%201707%E2%80%931722.%2010.1007/s13311-023-01446-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Baker, D., MacDougall, A., Kang, A. S., Schmierer, K., Giovannoni, G., &amp; Dobson, R. (2022). CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis. <em>Multiple Sclerosis and Related Disorders</em>, <em>57</em>, 103448. 10.1016/j.msard.2021.103448
</cite> [<a href="https://doi.org/10.1016/j.msard.2021.103448" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8642825/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34902760/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Baker,%20D.,%20MacDougall,%20A.,%20Kang,%20A.%20S.,%20Schmierer,%20K.,%20Giovannoni,%20G.,%20&amp;%20Dobson,%20R.%20(2022).%20CD19%20B%20cell%20repopulation%20after%20ocrelizumab,%20alemtuzumab%20and%20cladribine:%20Implications%20for%20SARS-CoV-2%20vaccinations%20in%20multiple%20sclerosis.%20Multiple%20Sclerosis%20and%20Related%20Disorders,%2057,%20103448.%2010.1016/j.msard.2021.103448" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Mrochen, A., Meuth, S. G., &amp; Pfeuffer, S. (2025). Should we stay or should we go? Recent insights on drug discontinuation in multiple sclerosis. <em>Neurological Research and Practice</em>, <em>7</em>(1), 25. 10.1186/s42466-025-00379-y
</cite> [<a href="https://doi.org/10.1186/s42466-025-00379-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12010584/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40254626/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mrochen,%20A.,%20Meuth,%20S.%20G.,%20&amp;%20Pfeuffer,%20S.%20(2025).%20Should%20we%20stay%20or%20should%20we%20go?%20Recent%20insights%20on%20drug%20discontinuation%20in%20multiple%20sclerosis.%20Neurological%20Research%20and%20Practice,%207(1),%2025.%2010.1186/s42466-025-00379-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Bayas, A., Mansmann, U., Ön, B. I., Hoffmann, V. S., Berthele, A., Mühlau, M., Kowarik,M. C., Krumbholz, M., Senel, M., Steuerwald, V., Naumann, M., Hartberger, J., Kerschensteiner,M., Oswald, E., Ruschil, C., Ziemann, U., Tumani, H., Vardakas, I., Albashiti, F.,Kramer, F., … ProVal-MS study group (2024). Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis, the ProVal-MS study. <em>Neurological research and practice</em>, <em>6</em>(1), 15. 10.1186/s42466-024-00310-x.</cite> [<a href="https://doi.org/10.1186/s42466-024-00310-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10918966/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38449051/" class="usa-link">PubMed</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). <em>Neurology</em>, <em>33</em>(11), 1444–1452. 10.1212/wnl.33.11.1444
</cite> [<a href="https://doi.org/10.1212/wnl.33.11.1444" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6685237/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kurtzke,%20J.%20F.%20(1983).%20Rating%20neurologic%20impairment%20in%20multiple%20sclerosis:%20An%20expanded%20disability%20status%20scale%20(EDSS).%20Neurology,%2033(11),%201444%E2%80%931452.%2010.1212/wnl.33.11.1444" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Kaufman, M., Moyer, D., &amp; Norton, J. (2000). The significant change for the timed 25-foot walk in the multiple sclerosis functional composite. <em>Multiple Sclerosis (Houndmills Basingstoke England)</em>, <em>6</em>(4), 286–290. 10.1177/135245850000600411
</cite> [<a href="https://doi.org/10.1177/135245850000600411" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10962550/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kaufman,%20M.,%20Moyer,%20D.,%20&amp;%20Norton,%20J.%20(2000).%20The%20significant%20change%20for%20the%20timed%2025-foot%20walk%20in%20the%20multiple%20sclerosis%20functional%20composite.%20Multiple%20Sclerosis%20(Houndmills%20Basingstoke%20England),%206(4),%20286%E2%80%93290.%2010.1177/135245850000600411" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Kappos, L., Wolinsky, J. S., Giovannoni, G., Arnold, D. L., Wang, Q., Bernasconi, C., Model, F., Koendgen, H., Manfrini, M., Belachew, S., &amp; Hauser, S. L. (2020). Contribution of Relapse-Independent progression vs Relapse-Associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled analysis of 2 randomized clinical trials. <em>JAMA Neurology</em>, <em>77</em>(9), 1132–1140. 10.1001/jamaneurol.2020.1568
</cite> [<a href="https://doi.org/10.1001/jamaneurol.2020.1568" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7281382/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32511687/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kappos,%20L.,%20Wolinsky,%20J.%20S.,%20Giovannoni,%20G.,%20Arnold,%20D.%20L.,%20Wang,%20Q.,%20Bernasconi,%20C.,%20Model,%20F.,%20Koendgen,%20H.,%20Manfrini,%20M.,%20Belachew,%20S.,%20&amp;%20Hauser,%20S.%20L.%20(2020).%20Contribution%20of%20Relapse-Independent%20progression%20vs%20Relapse-Associated%20worsening%20to%20overall%20confirmed%20disability%20accumulation%20in%20typical%20relapsing%20multiple%20sclerosis%20in%20a%20pooled%20analysis%20of%202%20randomized%20clinical%20trials.%20JAMA%20Neurology,%2077(9),%201132%E2%80%931140.%2010.1001/jamaneurol.2020.1568" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Wattjes, M. P., Ciccarelli, O., Reich, D. S., Banwell, B., de Stefano, N., Enzinger, C., Fazekas, F., Filippi, M., Frederiksen, J., Gasperini, C., Hacohen, Y., Kappos, L., Li, D. K. B., Mankad, K., Montalban, X., Newsome, S. D., Oh, J., Palace, J., Rocca, M. A., Sastre-Garriga, J., &amp; North American Imaging in Multiple Sclerosis Cooperative MRI guidelines working group. (2021). 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. <em>The Lancet Neurology</em>, <em>20</em>(8), 653–670. 10.1016/S1474-4422(21)00095-8
</cite> [<a href="https://doi.org/10.1016/S1474-4422(21)00095-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34139157/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wattjes,%20M.%20P.,%20Ciccarelli,%20O.,%20Reich,%20D.%20S.,%20Banwell,%20B.,%20de%20Stefano,%20N.,%20Enzinger,%20C.,%20Fazekas,%20F.,%20Filippi,%20M.,%20Frederiksen,%20J.,%20Gasperini,%20C.,%20Hacohen,%20Y.,%20Kappos,%20L.,%20Li,%20D.%20K.%20B.,%20Mankad,%20K.,%20Montalban,%20X.,%20Newsome,%20S.%20D.,%20Oh,%20J.,%20Palace,%20J.,%20Rocca,%20M.%20A.,%20Sastre-Garriga,%20J.,%20&amp;%20North%20American%20Imaging%20in%20Multiple%20Sclerosis%20Cooperative%20MRI%20guidelines%20working%20group.%20(2021).%202021%20MAGNIMS-CMSC-NAIMS%20consensus%20recommendations%20on%20the%20use%20of%20MRI%20in%20patients%20with%20multiple%20sclerosis.%20The%20Lancet%20Neurology,%2020(8),%20653%E2%80%93670.%2010.1016/S1474-4422(21)00095-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Dati, F., Schumann, G., Thomas, L., Aguzzi, F., Baudner, S., Bienvenu, J., Blaabjerg, O., Blirup-Jensen, S., Carlström, A., Petersen, P. H., Johnson, A. M., Milford-Ward, A., Ritchie, R. F., Svendsen, P. J., &amp; Whicher, J. (1996). Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists. <em>European journal of clinical chemistry and clinical biochemistry: journal of the Forum of European Clinical Chemistry Societies</em>, <em>34</em>(6), 517–520.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/8831057/" class="usa-link">PubMed</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Katzmann, J. A., Clark, R. J., Abraham, R. S., Bryant, S., Lymp, J. F., Bradwell, A. R., &amp; Kyle, R. A. (2002). Serum reference intervals and diagnostic ranges for free kappa and free lambda Immunoglobulin light chains: Relative sensitivity for detection of monoclonal light chains. <em>Clinical Chemistry</em>, <em>48</em>(9), 1437–1444.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/12194920/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Katzmann,%20J.%20A.,%20Clark,%20R.%20J.,%20Abraham,%20R.%20S.,%20Bryant,%20S.,%20Lymp,%20J.%20F.,%20Bradwell,%20A.%20R.,%20&amp;%20Kyle,%20R.%20A.%20(2002).%20Serum%20reference%20intervals%20and%20diagnostic%20ranges%20for%20free%20kappa%20and%20free%20lambda%20Immunoglobulin%20light%20chains:%20Relative%20sensitivity%20for%20detection%20of%20monoclonal%20light%20chains.%20Clinical%20Chemistry,%2048(9),%201437%E2%80%931444." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Cossarizza, A., Chang, H. D., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä,I., Andreata, F., Annunziato, F., Arranz, E., Bacher, P., Bari, S., Barnaba, V., Barros-Martins,J., Baumjohann, D., Beccaria, C. G., Bernardo, D., Boardman, D. A., Borger, J., Böttcher,C., … Yang, J. (2021). Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition). <em>European journal of immunology</em>, <em>51</em>(12), 2708–3145. 10.1002/eji.202170126.</cite> [<a href="https://doi.org/10.1002/eji.202170126" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11115438/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34910301/" class="usa-link">PubMed</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Das, M., Mead, G. P., Sreekanth, V., Anderson, J., Blair, S., Howe, T., Cavet, J., &amp; Liakopoulou, E. (2005). Serum free light chain (SFLC) concentration kinetics in patients receiving bortezomib: Temporary Inhibition of protein synthesis and early biomarker for disease response. <em>Blood</em>, <em>106</em>(11), 5094. 10.1182/blood.V106.11.5094.5094</cite> [<a href="https://scholar.google.com/scholar_lookup?Das,%20M.,%20Mead,%20G.%20P.,%20Sreekanth,%20V.,%20Anderson,%20J.,%20Blair,%20S.,%20Howe,%20T.,%20Cavet,%20J.,%20&amp;%20Liakopoulou,%20E.%20(2005).%20Serum%20free%20light%20chain%20(SFLC)%20concentration%20kinetics%20in%20patients%20receiving%20bortezomib:%20Temporary%20Inhibition%20of%20protein%20synthesis%20and%20early%20biomarker%20for%20disease%20response.%20Blood,%20106(11),%205094.%2010.1182/blood.V106.11.5094.5094" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Mead, G. P., Reid, S. D., Augustson, B. M., Drayson, M. T., Bradwell, A. R., &amp; Child, J. A. (2004). Correlation of serum free light chains and bone marrow plasma cell infiltration in multiple myeloma. <em>Blood</em>, <em>104</em>(11), 4865. 10.1182/blood.V104.11.4865.4865</cite> [<a href="https://scholar.google.com/scholar_lookup?Mead,%20G.%20P.,%20Reid,%20S.%20D.,%20Augustson,%20B.%20M.,%20Drayson,%20M.%20T.,%20Bradwell,%20A.%20R.,%20&amp;%20Child,%20J.%20A.%20(2004).%20Correlation%20of%20serum%20free%20light%20chains%20and%20bone%20marrow%20plasma%20cell%20infiltration%20in%20multiple%20myeloma.%20Blood,%20104(11),%204865.%2010.1182/blood.V104.11.4865.4865" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Robinson, W. H., Fiorentino, D., Chung, L., Moreland, L. W., Deodhar, M., Harler, M. B., Saulsbery, C., &amp; Kunder, R. (2024). Cutting-edge approaches to B-cell depletion in autoimmune diseases. <em>Frontiers in Immunology</em>, <em>15</em>, 1454747. 10.3389/fimmu.2024.1454747
</cite> [<a href="https://doi.org/10.3389/fimmu.2024.1454747" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11497632/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39445025/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Robinson,%20W.%20H.,%20Fiorentino,%20D.,%20Chung,%20L.,%20Moreland,%20L.%20W.,%20Deodhar,%20M.,%20Harler,%20M.%20B.,%20Saulsbery,%20C.,%20&amp;%20Kunder,%20R.%20(2024).%20Cutting-edge%20approaches%20to%20B-cell%20depletion%20in%20autoimmune%20diseases.%20Frontiers%20in%20Immunology,%2015,%201454747.%2010.3389/fimmu.2024.1454747" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Willison, A. G., Hagler, R., Weise, M., Elben, S., Huntemann, N., Masanneck, L.,Pfeuffer, S., Lichtenberg, S., Golombeck, K. S., Preuth, L. M., Rolfes, L., Öztürk,M., Ruck, T., Melzer, N., Korsen, M., Hauser, S. L., Hartung, H. P., Lang, P. A.,Pawlitzki, M., Räuber, S., … Meuth, S. G. (2025). Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple Sclerosis. <em>Cells</em>, <em>14</em>(7), 552. 10.3390/cells14070552.</cite> [<a href="https://doi.org/10.3390/cells14070552" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11988809/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40214505/" class="usa-link">PubMed</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Konen, F. F., Schwenkenbecher, P., Wurster, U., Jendretzky, K. F., Möhn, N., Gingele, S., Sühs, K. W., Hannich, M. J., Grothe, M., Witte, T., Stangel, M., Süße, M., &amp; Skripuletz, T. (2021). The influence of renal function impairment on kappa free light chains in cerebrospinal fluid. <em>Journal of Central Nervous System Disease</em>, <em>13</em>, 11795735211042166. 10.1177/11795735211042166
</cite> [<a href="https://doi.org/10.1177/11795735211042166" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8619759/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34840504/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Konen,%20F.%20F.,%20Schwenkenbecher,%20P.,%20Wurster,%20U.,%20Jendretzky,%20K.%20F.,%20M%C3%B6hn,%20N.,%20Gingele,%20S.,%20S%C3%BChs,%20K.%20W.,%20Hannich,%20M.%20J.,%20Grothe,%20M.,%20Witte,%20T.,%20Stangel,%20M.,%20S%C3%BC%C3%9Fe,%20M.,%20&amp;%20Skripuletz,%20T.%20(2021).%20The%20influence%20of%20renal%20function%20impairment%20on%20kappa%20free%20light%20chains%20in%20cerebrospinal%20fluid.%20Journal%20of%20Central%20Nervous%20System%20Disease,%2013,%2011795735211042166.%2010.1177/11795735211042166" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Hannich, M. J., Konen, F. F., Gag, K., Alkhayer, A., Türker, S. N., Budde, K., Nauck, M., Wurster, U., Dressel, A., Skripuletz, T., &amp; Süße, M. (2024). Implications of monoclonal gammopathy and isoelectric focusing pattern 5 on the free light chain kappa diagnostics in cerebrospinal fluid. <em>Clinical Chemistry and Laboratory Medicine</em>, <em>63</em>(1), 147–153. 10.1515/cclm-2023-1468
</cite> [<a href="https://doi.org/10.1515/cclm-2023-1468" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39039726/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hannich,%20M.%20J.,%20Konen,%20F.%20F.,%20Gag,%20K.,%20Alkhayer,%20A.,%20T%C3%BCrker,%20S.%20N.,%20Budde,%20K.,%20Nauck,%20M.,%20Wurster,%20U.,%20Dressel,%20A.,%20Skripuletz,%20T.,%20&amp;%20S%C3%BC%C3%9Fe,%20M.%20(2024).%20Implications%20of%20monoclonal%20gammopathy%20and%20isoelectric%20focusing%20pattern%205%20on%20the%20free%20light%20chain%20kappa%20diagnostics%20in%20cerebrospinal%20fluid.%20Clinical%20Chemistry%20and%20Laboratory%20Medicine,%2063(1),%20147%E2%80%93153.%2010.1515/cclm-2023-1468" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Tumani, H., Tourtellotte, W. W., Peter, J. B., &amp; Felgenhauer, K. (1998). Acute optic neuritis: Combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis. The optic neuritis study group. <em>Journal of the Neurological Sciences</em>, <em>155</em>(1), 44–49. 10.1016/s0022-510x(97)00272-4
</cite> [<a href="https://doi.org/10.1016/s0022-510x(97)00272-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9562321/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tumani,%20H.,%20Tourtellotte,%20W.%20W.,%20Peter,%20J.%20B.,%20&amp;%20Felgenhauer,%20K.%20(1998).%20Acute%20optic%20neuritis:%20Combined%20immunological%20markers%20and%20magnetic%20resonance%20imaging%20predict%20subsequent%20development%20of%20multiple%20sclerosis.%20The%20optic%20neuritis%20study%20group.%20Journal%20of%20the%20Neurological%20Sciences,%20155(1),%2044%E2%80%9349.%2010.1016/s0022-510x(97)00272-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Klein, A., Selter, R. C., Hapfelmeier, A., Berthele, A., Müller-Myhsok, B., Pongratz, V., Gasperi, C., Zimmer, C., Mühlau, M., &amp; Hemmer, B. (2019). CSF parameters associated with early MRI activity in patients with MS. <em>Neurology(R) Neuroimmunology &amp; Neuroinflammation</em>, <em>6</em>(4), e573. 10.1212/NXI.0000000000000573
</cite> [<a href="https://doi.org/10.1212/NXI.0000000000000573" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6624100/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31355309/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Klein,%20A.,%20Selter,%20R.%20C.,%20Hapfelmeier,%20A.,%20Berthele,%20A.,%20M%C3%BCller-Myhsok,%20B.,%20Pongratz,%20V.,%20Gasperi,%20C.,%20Zimmer,%20C.,%20M%C3%BChlau,%20M.,%20&amp;%20Hemmer,%20B.%20(2019).%20CSF%20parameters%20associated%20with%20early%20MRI%20activity%20in%20patients%20with%20MS.%20Neurology(R)%20Neuroimmunology%20&amp;%20Neuroinflammation,%206(4),%20e573.%2010.1212/NXI.0000000000000573" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Makshakov, G., Nazarov, V., Kochetova, O., Surkova, E., Lapin, S., &amp; Evdoshenko, E. (2015). Diagnostic and prognostic value of the cerebrospinal fluid concentration of Immunoglobulin free light chains in clinically isolated syndrome with conversion to multiple sclerosis. <em>PloS One</em>, <em>10</em>(11), e0143375. 10.1371/journal.pone.0143375
</cite> [<a href="https://doi.org/10.1371/journal.pone.0143375" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4659555/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26606531/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Makshakov,%20G.,%20Nazarov,%20V.,%20Kochetova,%20O.,%20Surkova,%20E.,%20Lapin,%20S.,%20&amp;%20Evdoshenko,%20E.%20(2015).%20Diagnostic%20and%20prognostic%20value%20of%20the%20cerebrospinal%20fluid%20concentration%20of%20Immunoglobulin%20free%20light%20chains%20in%20clinically%20isolated%20syndrome%20with%20conversion%20to%20multiple%20sclerosis.%20PloS%20One,%2010(11),%20e0143375.%2010.1371/journal.pone.0143375" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Rudick, R. A., Medendorp, S. V., Namey, M., Boyle, S., &amp; Fischer, J. (1995). Multiple sclerosis progression in a natural history study: Predictive value of cerebrospinal fluid free kappa light chains. <em>Multiple Sclerosis (Houndmills Basingstoke England)</em>, <em>1</em>(3), 150–155. 10.1177/135245859500100303
</cite> [<a href="https://doi.org/10.1177/135245859500100303" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9345445/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rudick,%20R.%20A.,%20Medendorp,%20S.%20V.,%20Namey,%20M.,%20Boyle,%20S.,%20&amp;%20Fischer,%20J.%20(1995).%20Multiple%20sclerosis%20progression%20in%20a%20natural%20history%20study:%20Predictive%20value%20of%20cerebrospinal%20fluid%20free%20kappa%20light%20chains.%20Multiple%20Sclerosis%20(Houndmills%20Basingstoke%20England),%201(3),%20150%E2%80%93155.%2010.1177/135245859500100303" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Vecchio, D., Crespi, I., Virgilio, E., Naldi, P., Campisi, M. P., Serino, R., Dianzani, U., Bellomo, G., Cantello, R., &amp; Comi, C. (2019). Kappa free light chains could predict early disease course in multiple sclerosis. <em>Multiple Sclerosis and Related Disorders</em>, <em>30</em>, 81–84. 10.1016/j.msard.2019.02.001
</cite> [<a href="https://doi.org/10.1016/j.msard.2019.02.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30738877/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vecchio,%20D.,%20Crespi,%20I.,%20Virgilio,%20E.,%20Naldi,%20P.,%20Campisi,%20M.%20P.,%20Serino,%20R.,%20Dianzani,%20U.,%20Bellomo,%20G.,%20Cantello,%20R.,%20&amp;%20Comi,%20C.%20(2019).%20Kappa%20free%20light%20chains%20could%20predict%20early%20disease%20course%20in%20multiple%20sclerosis.%20Multiple%20Sclerosis%20and%20Related%20Disorders,%2030,%2081%E2%80%9384.%2010.1016/j.msard.2019.02.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Salavisa, M., Paixão, P., Ladeira, A. F., Mendes, A., Correia, A. S., Viana, J. F., &amp; Viana-Baptista, M. (2020). Prognostic value of kappa free light chains determination in first-ever multiple sclerosis relapse. <em>Journal of Neuroimmunology</em>, <em>347</em>, 577355. 10.1016/j.jneuroim.2020.577355
</cite> [<a href="https://doi.org/10.1016/j.jneuroim.2020.577355" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32795735/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Salavisa,%20M.,%20Paix%C3%A3o,%20P.,%20Ladeira,%20A.%20F.,%20Mendes,%20A.,%20Correia,%20A.%20S.,%20Viana,%20J.%20F.,%20&amp;%20Viana-Baptista,%20M.%20(2020).%20Prognostic%20value%20of%20kappa%20free%20light%20chains%20determination%20in%20first-ever%20multiple%20sclerosis%20relapse.%20Journal%20of%20Neuroimmunology,%20347,%20577355.%2010.1016/j.jneuroim.2020.577355" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Berek, K., Bsteh, G., Auer, M., Di Pauli, F., Grams, A., Milosavljevic, D., Poskaite, P., Schnabl, C., Wurth, S., Zinganell, A., Berger, T., Walde, J., Deisenhammer, F., &amp; Hegen, H. (2021). Kappa-Free light chains in CSF predict early multiple sclerosis disease activity. <em>Neurology(R) Neuroimmunology &amp; Neuroinflammation</em>, <em>8</em>(4), e1005. 10.1212/NXI.0000000000001005
</cite> [<a href="https://doi.org/10.1212/NXI.0000000000001005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8168046/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34049994/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Berek,%20K.,%20Bsteh,%20G.,%20Auer,%20M.,%20Di%20Pauli,%20F.,%20Grams,%20A.,%20Milosavljevic,%20D.,%20Poskaite,%20P.,%20Schnabl,%20C.,%20Wurth,%20S.,%20Zinganell,%20A.,%20Berger,%20T.,%20Walde,%20J.,%20Deisenhammer,%20F.,%20&amp;%20Hegen,%20H.%20(2021).%20Kappa-Free%20light%20chains%20in%20CSF%20predict%20early%20multiple%20sclerosis%20disease%20activity.%20Neurology(R)%20Neuroimmunology%20&amp;%20Neuroinflammation,%208(4),%20e1005.%2010.1212/NXI.0000000000001005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Presslauer, S., Milosavljevic, D., Brücke, T., Bayer, P., &amp; Hübl, W. (2008). Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis. <em>Journal of Neurology</em>, <em>255</em>(10), 1508–1514. 10.1007/s00415-008-0954-z
</cite> [<a href="https://doi.org/10.1007/s00415-008-0954-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18685917/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Presslauer,%20S.,%20Milosavljevic,%20D.,%20Br%C3%BCcke,%20T.,%20Bayer,%20P.,%20&amp;%20H%C3%BCbl,%20W.%20(2008).%20Elevated%20levels%20of%20kappa%20free%20light%20chains%20in%20CSF%20support%20the%20diagnosis%20of%20multiple%20sclerosis.%20Journal%20of%20Neurology,%20255(10),%201508%E2%80%931514.%2010.1007/s00415-008-0954-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Duranti, F., Pieri, M., Centonze, D., Buttari, F., Bernardini, S., &amp; Dessi, M. (2013). Determination of κFLC and κ index in cerebrospinal fluid: A valid alternative to assess intrathecal Immunoglobulin synthesis. <em>Journal of Neuroimmunology</em>, <em>263</em>(1–2), 116–120. 10.1016/j.jneuroim.2013.07.006
</cite> [<a href="https://doi.org/10.1016/j.jneuroim.2013.07.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23916392/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Duranti,%20F.,%20Pieri,%20M.,%20Centonze,%20D.,%20Buttari,%20F.,%20Bernardini,%20S.,%20&amp;%20Dessi,%20M.%20(2013).%20Determination%20of%20%CE%BAFLC%20and%20%CE%BA%20index%20in%20cerebrospinal%20fluid:%20A%20valid%20alternative%20to%20assess%20intrathecal%20Immunoglobulin%20synthesis.%20Journal%20of%20Neuroimmunology,%20263(1%E2%80%932),%20116%E2%80%93120.%2010.1016/j.jneuroim.2013.07.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Desplat-Jégo, S., Feuillet, L., Pelletier, J., Bernard, D., Chérif, A. A., &amp; Boucraut, J. (2005). Quantification of Immunoglobulin free light chains in cerebrospinal fluid by nephelometry. <em>Journal of Clinical Immunology</em>, <em>25</em>(4), 338–345. 10.1007/s10875-005-5371-9
</cite> [<a href="https://doi.org/10.1007/s10875-005-5371-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16133990/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Desplat-J%C3%A9go,%20S.,%20Feuillet,%20L.,%20Pelletier,%20J.,%20Bernard,%20D.,%20Ch%C3%A9rif,%20A.%20A.,%20&amp;%20Boucraut,%20J.%20(2005).%20Quantification%20of%20Immunoglobulin%20free%20light%20chains%20in%20cerebrospinal%20fluid%20by%20nephelometry.%20Journal%20of%20Clinical%20Immunology,%2025(4),%20338%E2%80%93345.%2010.1007/s10875-005-5371-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Gaetani, L., Di Carlo, M., Brachelente, G., Valletta, F., Eusebi, P., Mancini, A., Gentili, L., Borrelli, A., Calabresi, P., Sarchielli, P., Ferri, C., Villa, A., &amp; Di Filippo, M. (2020). Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis. <em>Journal of Neuroimmunology</em>, <em>339</em>, 577108. 10.1016/j.jneuroim.2019.577108
</cite> [<a href="https://doi.org/10.1016/j.jneuroim.2019.577108" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31743879/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gaetani,%20L.,%20Di%20Carlo,%20M.,%20Brachelente,%20G.,%20Valletta,%20F.,%20Eusebi,%20P.,%20Mancini,%20A.,%20Gentili,%20L.,%20Borrelli,%20A.,%20Calabresi,%20P.,%20Sarchielli,%20P.,%20Ferri,%20C.,%20Villa,%20A.,%20&amp;%20Di%20Filippo,%20M.%20(2020).%20Cerebrospinal%20fluid%20free%20light%20chains%20compared%20to%20oligoclonal%20bands%20as%20biomarkers%20in%20multiple%20sclerosis.%20Journal%20of%20Neuroimmunology,%20339,%20577108.%2010.1016/j.jneuroim.2019.577108" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Nazarov, V., Makshakov, G., Kalinin, I., Lapin, S., Surkova, E., Mikhailova, L., Gilburd, B., Skoromets, A., &amp; Evdoshenko, E. (2018). Concentrations of Immunoglobulin free light chains in cerebrospinal fluid predict increased level of brain atrophy in multiple sclerosis. <em>Immunologic Research</em>, <em>66</em>(6), 761–767. 10.1007/s12026-018-9058-8
</cite> [<a href="https://doi.org/10.1007/s12026-018-9058-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30635824/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nazarov,%20V.,%20Makshakov,%20G.,%20Kalinin,%20I.,%20Lapin,%20S.,%20Surkova,%20E.,%20Mikhailova,%20L.,%20Gilburd,%20B.,%20Skoromets,%20A.,%20&amp;%20Evdoshenko,%20E.%20(2018).%20Concentrations%20of%20Immunoglobulin%20free%20light%20chains%20in%20cerebrospinal%20fluid%20predict%20increased%20level%20of%20brain%20atrophy%20in%20multiple%20sclerosis.%20Immunologic%20Research,%2066(6),%20761%E2%80%93767.%2010.1007/s12026-018-9058-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Puthenparampil, M., Altinier, S., Stropparo, E., Zywicki, S., Poggiali, D., Cazzola, C., Toffanin, E., Ruggero, S., Grassivaro, F., Zaninotto, M., Plebani, M., &amp; Gallo, P. (2018). Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination. <em>Multiple Sclerosis and Related Disorders</em>, <em>25</em>, 241–245. 10.1016/j.msard.2018.08.002
</cite> [<a href="https://doi.org/10.1016/j.msard.2018.08.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30130707/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Puthenparampil,%20M.,%20Altinier,%20S.,%20Stropparo,%20E.,%20Zywicki,%20S.,%20Poggiali,%20D.,%20Cazzola,%20C.,%20Toffanin,%20E.,%20Ruggero,%20S.,%20Grassivaro,%20F.,%20Zaninotto,%20M.,%20Plebani,%20M.,%20&amp;%20Gallo,%20P.%20(2018).%20Intrathecal%20K%20free%20light%20chain%20synthesis%20in%20multiple%20sclerosis%20at%20clinical%20onset%20associates%20with%20local%20IgG%20production%20and%20improves%20the%20diagnostic%20value%20of%20cerebrospinal%20fluid%20examination.%20Multiple%20Sclerosis%20and%20Related%20Disorders,%2025,%20241%E2%80%93245.%2010.1016/j.msard.2018.08.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Hassan-Smith, G., Durant, L., Tsentemeidou, A., Assi, L. K., Faint, J. M., Kalra, S., Douglas, M. R., &amp; Curnow, S. J. (2014). High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis. <em>Journal of Neuroimmunology</em>, <em>276</em>(1–2), 175–179. 10.1016/j.jneuroim.2014.08.003
</cite> [<a href="https://doi.org/10.1016/j.jneuroim.2014.08.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25146968/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hassan-Smith,%20G.,%20Durant,%20L.,%20Tsentemeidou,%20A.,%20Assi,%20L.%20K.,%20Faint,%20J.%20M.,%20Kalra,%20S.,%20Douglas,%20M.%20R.,%20&amp;%20Curnow,%20S.%20J.%20(2014).%20High%20sensitivity%20and%20specificity%20of%20elevated%20cerebrospinal%20fluid%20kappa%20free%20light%20chains%20in%20suspected%20multiple%20sclerosis.%20Journal%20of%20Neuroimmunology,%20276(1%E2%80%932),%20175%E2%80%93179.%2010.1016/j.jneuroim.2014.08.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12372195/bin/42466_2025_419_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (12.6KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12372195/bin/42466_2025_419_MOESM2_ESM.jpg" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 2</a><sup> (55KB, jpg) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Neurological Research and Practice are provided here courtesy of <strong>Deutsche Gesellschaft für Neurologie e.V.</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s42466-025-00419-7"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/42466_2025_Article_419.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.7 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12372195/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12372195/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372195%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372195/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12372195/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12372195/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40847377/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12372195/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40847377/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12372195/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12372195/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="WIhwNqHA0WWwCnrOMxiKpPwBV9XqgpUwDbZxQMs39IrN8hrYe0PhM6R3k8CYuwQr">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
